In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Nymox Pharmaceutical Corp.. Trade Record

NASDAQ:NYMX Nymox Pharmaceutical Corp. stock gains 11.53% Exit Jun 25, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart NYMX Jun 13, 2019, priceSeries
About Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company markets its products in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, The Bahamas.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.28
Entry Date
Jun 13, 2019
Entry Price
1.53
Sell Date
Jun 25, 2019
Sell Price
1.71
Net Gain
11.53%
Hold Time
8 Trading Days